ATE489090T1 - Verringerung von übergewicht oder fettsucht - Google Patents

Verringerung von übergewicht oder fettsucht

Info

Publication number
ATE489090T1
ATE489090T1 AT07766498T AT07766498T ATE489090T1 AT E489090 T1 ATE489090 T1 AT E489090T1 AT 07766498 T AT07766498 T AT 07766498T AT 07766498 T AT07766498 T AT 07766498T AT E489090 T1 ATE489090 T1 AT E489090T1
Authority
AT
Austria
Prior art keywords
obesity
reducing overweight
reduction
weight gain
overweight
Prior art date
Application number
AT07766498T
Other languages
English (en)
Inventor
Nagy Peter Literati
Zoltan Szilvassy
Kalman Tory
Laszlo Vigh
Kalman Takacs
Jozsef Mandl
Balazs Suemegi
Sandor Bernath
Attila Kolonics
Gabor Balogh
Janos Egri
Original Assignee
N Gene Res Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by N Gene Res Lab Inc filed Critical N Gene Res Lab Inc
Application granted granted Critical
Publication of ATE489090T1 publication Critical patent/ATE489090T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
AT07766498T 2006-11-02 2007-07-23 Verringerung von übergewicht oder fettsucht ATE489090T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US85611706P 2006-11-02 2006-11-02
US11/687,945 US7763601B2 (en) 2006-11-02 2007-03-19 Prevention and treatment of obesity
PCT/HU2007/000066 WO2008053256A1 (en) 2006-11-02 2007-07-23 Reduction of overweight or obesity

Publications (1)

Publication Number Publication Date
ATE489090T1 true ATE489090T1 (de) 2010-12-15

Family

ID=38592002

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07766498T ATE489090T1 (de) 2006-11-02 2007-07-23 Verringerung von übergewicht oder fettsucht

Country Status (20)

Country Link
US (1) US7763601B2 (de)
EP (1) EP2089031B1 (de)
JP (1) JP2010509199A (de)
KR (1) KR20090082442A (de)
AT (1) ATE489090T1 (de)
AU (1) AU2007315931A1 (de)
BR (1) BRPI0717867A2 (de)
CA (1) CA2668382A1 (de)
DE (1) DE602007010819D1 (de)
DK (1) DK2089031T3 (de)
HK (1) HK1131737A1 (de)
HR (1) HRP20110023T1 (de)
IL (1) IL198296A (de)
MX (1) MX2009004538A (de)
NO (1) NO20092025L (de)
PL (1) PL2089031T3 (de)
PT (1) PT2089031E (de)
RU (1) RU2443417C2 (de)
SI (1) SI2089031T1 (de)
WO (1) WO2008053256A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11241420B2 (en) 2007-04-11 2022-02-08 Omeros Corporation Compositions and methods for prophylaxis and treatment of addictions
US20160331729A9 (en) 2007-04-11 2016-11-17 Omeros Corporation Compositions and methods for prophylaxis and treatment of addictions
CN105250285B (zh) 2007-04-11 2019-09-06 奥默罗斯公司 预防和治疗成瘾的组合物和方法
US20090281143A1 (en) * 2007-12-10 2009-11-12 N-Gene Research Laboratories, Inc. Dose Reduction of a Cannabinoid CB1 Receptor Antagonist in the Treatment of Overweight or Obesity
HUP1100444A2 (en) 2011-08-17 2013-02-28 Pharma Gene Sa Pharmaceutical composition
HUP1100445A2 (en) 2011-08-17 2013-02-28 Pharma Gene Sa Pharmaceutical composition
HUP1800298A1 (hu) 2018-08-30 2020-05-28 N Gene Res Laboratories Inc Gyógyszerkombináció béta-receptor blokkolók hatásának módosítására és a mellékhatások csökkentésére

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4187220A (en) * 1977-08-30 1980-02-05 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara R.T. New O-(3-amino-2-hydroxy-propyl)-amidoxime derivatives, process for the preparation thereof and pharmaceutical compositions containing same
US4287220A (en) * 1980-02-19 1981-09-01 Frito-Lay, Inc. Hull containing compositions
HU207988B (en) * 1988-10-20 1993-07-28 Biorex Kutato Fejlesztoe Kft Process for producing halogenides of o-/3-amino-2-hydroxy-propyl/hydroximic acid and pharmaceutical compositions containing them as active components
HU9502843D0 (en) * 1995-09-29 1995-11-28 Livigene Ltd Pharmaceutical composition
US6884424B2 (en) * 1995-12-22 2005-04-26 N-Gene Research Laboratories Inc. Method for treating the pathological lesions of the skin that develop by ultraviolet radiation of the sunlight
US6458371B1 (en) * 1995-12-22 2002-10-01 Medgene, Limited Cosmetic composition and a method for the prevention and/or reduction of the photoaging processes of the skin
HU9701081D0 (en) * 1997-06-23 1997-08-28 Gene Research Lab Inc N Pharmaceutical composition of antitumoral activity
HUP9701080A3 (en) * 1997-06-23 1999-05-28 Gene Res Lab Inc New York N Pharmaceutical composition containing a compound of antiviral activity and a hydroximic acid ester derivative
AU5296799A (en) 1998-08-03 2000-02-28 N-Gene Kutato Kft. Pharmaceutical compositions against autoimmune diseases
UA65635C2 (uk) * 1998-09-03 2004-04-15 Н-Гене Кутато Кфт. НЕНАСИЧЕНІ ПОХІДНІ ГІДРОКСИМОВОЇ КИСЛОТИ, ЩО МАЮТЬ ВЛАСТИВОСТІ ІНГІБІТОРІВ NAD<sup>+</sup>-ADP-РИБОЗИЛТРАНСФЕРАЗИ
DK1408966T3 (da) 2001-07-17 2008-06-16 N Gene Res Lab Inc Synergistiske farmaceutiske kombinationer til forebyggelse eller behandling af diabetes
HUP0401177A2 (en) 2004-06-14 2007-09-28 N Gene Res Lab Inc Pharmaceutical composition for increasing the mitochondrial genesis
HUP0401176A2 (en) 2004-06-14 2007-09-28 N Gene Res Lab Inc Pharmaceutical composition having prpkinetic effect
HUP0500145A2 (en) 2005-01-28 2006-11-28 Gene Res Lab N Use of o-(3-piperidino-2-hydroxy-1-propyl)-nicotinic amidoxime for preparation of medicaments against oral diseases
US7994222B2 (en) 2006-09-05 2011-08-09 Bipar Sciences, Inc. Monitoring of the inhibition of fatty acid synthesis by iodo-nitrobenzamide compounds

Also Published As

Publication number Publication date
IL198296A0 (en) 2010-02-17
KR20090082442A (ko) 2009-07-30
HK1131737A1 (en) 2010-02-05
DK2089031T3 (da) 2011-02-14
EP2089031A1 (de) 2009-08-19
SI2089031T1 (sl) 2011-04-29
EP2089031B1 (de) 2010-11-24
US20080108673A1 (en) 2008-05-08
JP2010509199A (ja) 2010-03-25
HRP20110023T1 (hr) 2011-04-30
NO20092025L (no) 2009-06-02
RU2443417C2 (ru) 2012-02-27
WO2008053256A1 (en) 2008-05-08
PL2089031T3 (pl) 2011-05-31
BRPI0717867A2 (pt) 2013-10-29
CA2668382A1 (en) 2008-05-08
MX2009004538A (es) 2009-05-22
IL198296A (en) 2011-09-27
AU2007315931A1 (en) 2008-05-08
DE602007010819D1 (de) 2011-01-05
PT2089031E (pt) 2011-02-24
RU2009119567A (ru) 2010-12-10
US7763601B2 (en) 2010-07-27

Similar Documents

Publication Publication Date Title
ATE489090T1 (de) Verringerung von übergewicht oder fettsucht
EP1730163A4 (de) Pharmazeutische salze von 3-o-(3,3-dimethylsuccinyl)betulinsäure
WO2007087395A3 (en) UNSATURATED mTOR INHIBITORS
MY148723A (en) Use of pinolenic acid for the treatment of obesity
MY150661A (en) Pyridin-3-yl derivatives as immunomodulating agents
MY140514A (en) Triazolopyridine derivatives as inhibitors of lipases and phospholipases
AU2011201462B2 (en) Method of Administering Pirfenidone Therapy
MY143407A (en) Indazole derivatives as inhibitors of hormone sensitive lipase
UA115320C2 (uk) Інгібітори кінази
WO2008142055A3 (en) Antiviral agents
NO20083708L (no) 4-Fenyl-tiazol-5-karboksylsyre og 4-fenyl-tiazol-5-karboksylmider som PLK1-inhibitorer
UA97348C2 (en) HETEROCYCLIC NF-kB INHIBITORS
JP2007506758A5 (ja) ４−（１−ベンゾフラン−３−イル−メチリデンアミノオキシ−プロポキシ）−安息香酸誘導体および線溶系の障害、血栓症の治療用のｐａｉ−１阻害剤としての関連化合物
IL185457A0 (en) 5-phenyl-pentanoic acid derivatives as metrix metalloproteinase inhibitors for the treatment of asthma and other diseases
WO2005123049A3 (en) A pharmaceutical composition for increasing the mitochondrial genesis
NO20071399L (no) VLA-4-antagonister
HK1131736A1 (en) A pharmaceutical composition having antipsychotic, antidepressant or antiepileptic activity with reduced side effect
TW200602008A (en) Plaster
TW200640446A (en) Prophylactic anti-stress agent
TN2012000093A1 (en) Therapeutic agent for anxiety disorders
WO2011058336A3 (en) Tablet comprising gum arabic
NO20090292L (no) Fenyleddiksyrederivater
NO20080740L (no) Heterocyklylamid-substituerte tiazoler, pyrroler og tiofener
UA96312C2 (ru) Применение о-(3-пиперидино-2-гидрокси-1-пропил)никотинамидоксима для уменьшения чрезмерной массы тела или ожирения
UA59517U (ru) Фармацевтическая композиция для лечения больных опиоидной зависимостью

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2089031

Country of ref document: EP